Henry Schein (NASDAQ:HSIC) Upgraded by Wall Street Zen to Buy Rating

Key Points

• Henry Schein has been upgraded from a "hold" rating to a "buy" rating by Wall Street Zen, indicating positive sentiment among analysts.
• The company's latest earnings results show a reported $1.10 EPS for the quarter, falling short of the consensus estimate by $0.09, even as revenue increased 3.3% year-over-year.
• Henry Schein's stock has shown a 1.5% increase during trading on Friday, reaching $67.03, with a current market cap of $8.13 billion.

Henry Schein (NASDAQ:HSIC - Get Free Report) was upgraded by equities researchers at Wall Street Zen from a "hold" rating to a "buy" rating in a report released on Friday.

HSIC has been the topic of several other reports. Barrington Research reissued an "outperform" rating and set a $78.00 price objective on shares of Henry Schein in a research report on Tuesday, September 23rd. Stifel Nicolaus reiterated a "hold" rating and set a $75.00 price target (down previously from $80.00) on shares of Henry Schein in a report on Friday, July 25th. JPMorgan Chase & Co. decreased their price objective on shares of Henry Schein from $80.00 to $76.00 and set an "overweight" rating for the company in a report on Thursday, August 7th. Weiss Ratings reiterated a "hold (c)" rating on shares of Henry Schein in a research note on Saturday, September 27th. Finally, Leerink Partners set a $75.00 price target on Henry Schein in a research note on Monday, July 14th. Five analysts have rated the stock with a Buy rating and eight have given a Hold rating to the stock. According to MarketBeat, the company has a consensus rating of "Hold" and an average price target of $76.67.

Henry Schein Stock Up 1.5%

NASDAQ HSIC traded up $1.00 during trading hours on Friday, reaching $67.03. 917,840 shares of the company's stock traded hands, compared to its average volume of 1,539,233. Henry Schein has a 52-week low of $60.56 and a 52-week high of $82.49. The company has a debt-to-equity ratio of 0.51, a current ratio of 1.41 and a quick ratio of 0.78. The firm has a 50-day simple moving average of $67.93 and a 200 day simple moving average of $69.00. The firm has a market cap of $8.13 billion, a PE ratio of 21.62, a PEG ratio of 2.18 and a beta of 0.81.

Henry Schein (NASDAQ:HSIC - Get Free Report) last released its earnings results on Tuesday, August 5th. The company reported $1.10 EPS for the quarter, missing the consensus estimate of $1.19 by ($0.09). Henry Schein had a return on equity of 14.36% and a net margin of 3.05%.The company had revenue of $3.24 billion during the quarter, compared to the consensus estimate of $3.22 billion. During the same period last year, the firm posted $1.23 earnings per share. The company's revenue was up 3.3% compared to the same quarter last year. Henry Schein has set its FY 2025 guidance at 4.800-4.940 EPS. Sell-side analysts anticipate that Henry Schein will post 4.74 EPS for the current fiscal year.

Institutional Trading of Henry Schein

Large investors have recently added to or reduced their stakes in the business. Ameriprise Financial Inc. boosted its stake in shares of Henry Schein by 3,275.2% during the 2nd quarter. Ameriprise Financial Inc. now owns 2,266,858 shares of the company's stock worth $165,594,000 after acquiring an additional 2,199,695 shares during the last quarter. Norges Bank bought a new position in Henry Schein in the 2nd quarter worth $89,476,000. M.D. Sass LLC purchased a new position in Henry Schein during the second quarter valued at $79,201,000. Schroder Investment Management Group grew its holdings in Henry Schein by 149.3% during the second quarter. Schroder Investment Management Group now owns 1,563,899 shares of the company's stock valued at $114,243,000 after purchasing an additional 936,471 shares during the period. Finally, Bank of America Corp DE increased its position in Henry Schein by 204.2% in the second quarter. Bank of America Corp DE now owns 995,375 shares of the company's stock worth $72,712,000 after buying an additional 668,182 shares in the last quarter. 96.62% of the stock is currently owned by institutional investors.

About Henry Schein

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.